These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14980978)

  • 1. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
    Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
    Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells.
    Yang YT; Ju TC; Yang DI
    J Neurochem; 2005 May; 93(3):513-25. PubMed ID: 15836611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-nitrosoglutathione and hypoxia-inducible factor-1 confer chemoresistance against carbamoylating cytotoxicity of BCNU in rat C6 glioma cells.
    Yang DI; Chen SD; Yin JH; Hsu CY
    Ann N Y Acad Sci; 2005 May; 1042():229-34. PubMed ID: 15965067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NO-mediated chemoresistance in C6 glioma cells.
    Yang DI; Yin JH; Mishra S; Mishra R; Hsu CY
    Ann N Y Acad Sci; 2002 May; 962():8-17. PubMed ID: 12076959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
    Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
    Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
    Yang JJ; Yin JH; Yang DI
    Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of hypoxia-inducible factor-1alpha in the prevention of cardiomyocyte injury induced by hypoxic preconditioning].
    Xu FF; Liu XH; Cai LR
    Sheng Li Xue Bao; 2004 Oct; 56(5):609-14. PubMed ID: 15497042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death.
    Yao SY; Soutto M; Sriram S
    J Neurosci Res; 2008 Aug; 86(11):2403-13. PubMed ID: 18438939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
    Zheng LT; Lee S; Yin GN; Mori K; Suk K
    J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.
    An WG; Kanekal M; Simon MC; Maltepe E; Blagosklonny MV; Neckers LM
    Nature; 1998 Mar; 392(6674):405-8. PubMed ID: 9537326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells.
    Dai S; Huang ML; Hsu CY; Chao KS
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1027-36. PubMed ID: 12605983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
    Stojković S; Podolski-Renić A; Dinić J; Stanković T; Banković J; Hadžić S; Paunović V; Isaković A; Tanić N; Pešić M
    Exp Cell Res; 2015 Jul; 335(2):248-57. PubMed ID: 26026740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain.
    Bergeron M; Gidday JM; Yu AY; Semenza GL; Ferriero DM; Sharp FR
    Ann Neurol; 2000 Sep; 48(3):285-96. PubMed ID: 10976634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms.
    Guo M; Song LP; Jiang Y; Liu W; Yu Y; Chen GQ
    Apoptosis; 2006 Jan; 11(1):67-77. PubMed ID: 16374551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of local anesthetics on cellular hypoxia-induced gene responses mediated by hypoxia-inducible factor 1.
    Nishi K; Hirota K; Takabuchi S; Oda S; Fukuda K; Adachi T; Shingu K
    J Anesth; 2005; 19(1):54-9. PubMed ID: 15674517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.
    Damert A; Machein M; Breier G; Fujita MQ; Hanahan D; Risau W; Plate KH
    Cancer Res; 1997 Sep; 57(17):3860-4. PubMed ID: 9288800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.